| | Business 
[ 2012-04-12 ] 
Johnson & Johnson fined $1.1bn in latest Risperdal case Drugs giant Johnson & Johnson (J&J) has been
ordered by a US judge to pay $1.1bn (£690m) for
downplaying the risks involved in taking its
anti-psychotic drug Risperdal.
The state of Arkansas sued J&J and its subsidiary
Janssen Pharmaceuticals over its marketing of the
drug in 2007.
A number of US states have already found the firms
guilty of similar charges and fined them
accordingly.
Janssen said it was "disappointed" with the
judge's decision.
The company added that if its motion for a retrial
was denied, it would appeal the fine.
"During the nearly three-week trial, Janssen
presented abundant evidence showing the company
acted responsibly and fully complied with all laws
and regulations regarding Risperdal," it said in a
written statement.
Appeal
In January, J&J agreed to pay $158m to settle
allegations of illegal marketing of Risperdal in
Texas.
Last year, a South Carolina judge ruled the
company must pay a $327m penalty after a jury
found it guilty of similar charges, while in 2010,
a Louisiana jury found the company violated the
state's Medicaid fraud act.
These two verdicts are currently under appeal.
Medicaid is a government-backed US public heath
programme for low-income citizens.
Comments ( 0 ): Have Your Say >>
Source - BBC

... go Back | |